Who Paid My Doc
A Phase 4, Randomized, Open-Label, Two-Arm Study Evaluating Implementa
Research payments
$1,298,863
Through program year 2025, $1,298,863 in research payments was reported against A Phase 4, Randomized, Open-Label, Two-Arm Study Evaluating Implementa, across 289 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $234,649 | 33 |
| 2024 | Research | $300,371 | 102 |
| 2023 | Research | $687,889 | 141 |
| 2022 | Research | $75,954 | 13 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Julian Torres Isasiga Bronx, NY Named on 22 payments
- Peter Shalit Seattle, WA Named on 18 payments
- Mitchell Whitehead Pensacola, FL Named on 18 payments
- Albert Liu San Francisco, CA Named on 16 payments
- Hadrian Holder Bridgeport, CT Named on 13 payments
- Alvin Kingcade Philadelphia, PA Named on 11 payments
- Taimur Khan Boston, MA Named on 10 payments
- William Valenti Rochester, NY Named on 10 payments
- Peter Ruane Los Angeles, CA Named on 8 payments
- Alexandre Lacasse Saint Louis, MO Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.